19      0

Variations, Innovations & Integrative Collaborations

Credits: None available.

Variations, Innovations & Integrative Collaborations

Learning Objectives

As a result of participating in this activity, learners will be better able to:

  • apply an improved understanding of immune dysfunction that occurs with age to the treatment of patients with chronic conditions
  • leverage interdisciplinary collaboration when solving clinical or scientific problems

Target Audience

Clinical researchers, clinician scientists, academicians, and administrators engaged in, conducting, or supporting medical research.


Collaboration is often a critical aspect of scientific research, which is dominated by complex problems, rapidly changing technology, dynamic growth of knowledge, and highly specialized areas of expertise. An individual scientist can seldom provide all of the expertise and resources necessary to address complex research problems5.

Collaboration among professionals from varied backgrounds and with varied occupational experiences may help to promote scientific innovation by broadening perspectives. In addition, a range of professional experiences may enable individuals to solve difficult research questions more easily by themselves6.

Desirable Physician Attributes

  • Medical Knowledge [ACGME/ABMS] about established and evolving biomedical, clinical, and cognate (e.g. epidemiological and social-behavioral) sciences and the application of this knowledge to patient care
  • Employ Evidenced-based Practice [IOM] Integrate best research with clinical expertise and patient values for optimum care, and participate in learning and research activities to the extent feasible
  • Systems-Based Practice [ACGME/ABMS] as manifested by actions that demonstrate an awareness of and responsiveness to the larger context and system of health care and the ability to effectively call on system resources to provide care that is of optimal value

Accreditation & Designation

Release date: This activity was released 8/27/2021.

Termination date: The content of this activity remains eligible for CME Credit until 8/26/2024, unless reviewed or amended prior to this date.

Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Neurovations Education designates this other activity (blended learning) for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Financial Relationships

Neither the presenter, reviewers nor any other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, any financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Additional Reading

  1. Tuttle, K. R. (2020). Impact of the COVID-19 pandemic on clinical research. Nature Reviews Nephrology, 16(10), 562-564.
  2. George, G., Lakhani, K. R., & Puranam, P. (2020). What has changed? The impact of Covid pandemic on the technology and innovation management research agenda. Journal of Management Studies, 57(8), 1754.
  3. Rodrigues, M. L., Nimrichter, L., & Cordero, R. J. (2016). The benefits of scientific mobility and international collaboration. FEMS microbiology letters, 363(21).
  4. Root-Bernstein, B., Siler, T., Brown, A., & Snelson, K. (2011). ArtScience: integrative collaboration to create a sustainable future.
  5. Hara, N., Solomon, P., Kim, S. L., & Sonnenwald, D. H. (2003). An emerging view of scientific collaboration: Scientists' perspectives on collaboration and factors that impact collaboration. Journal of the American Society for Information science and Technology, 54(10), 952-965.
  6. Yokomichi, H., Mochizuki, M., & Yamagata, Z. (2021). Encouraging Cross-Disciplinary Collaboration and Innovation in Epidemiology in Japan. Frontiers in Public Health, 9, 285.
  7. Gruver, A. L., Hudson, L. L., & Sempowski, G. D. (2007). Immunosenescence of ageing. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 211(2), 144-156.
  8. Caruso, C., Buffa, S., Candore, G., Colonna-Romano, G., Dunn-Walters, D., Kipling, D., & Pawelec, G. (2009). Mechanisms of immunosenescence. Immunity & Ageing, 6(1), 1-4.
  9. Goronzy, J. J., & Weyand, C. M. (2013). Understanding immunosenescence to improve responses to vaccines. Nature immunology, 14(5), 428-436.


  • 1.00 - Physician
  • 1.00 - Non-Physician